(Q37875688)

24 August 2017

Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases (English)

1 reference

nephrogenic systemic fibrosis

24 August 2017

0 references

1 reference

Zhitong Zou

1

1 reference

24 August 2017

Lin Ma

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

Indian Journal of Dermatology

24 August 2017

1 reference

24 August 2017

56

1 reference

24 August 2017

1

1 reference

24 August 2017

65-73

1 reference

Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation

24 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis in liver disease: a systematic review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Risk factors for NSF: a literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Patterns of late gadolinium enhancement in chronic hemodialysis patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Incidence of nephrogenic systemic fibrosis at two large medical centers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

The role of the hospital dermatologist in the diagnosis and treatment of calciphylaxis and nephrogenic systemic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy: report of two cases.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: center case review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium deposition in nephrogenic fibrosing dermopathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Approaches to liver biopsy techniques--revisited

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy in pediatric patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis associated with gadolinium use.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

NSF after Gadovist exposure: a case report and hypothesis of NSF development

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Sclerotic bodies in nephrogenic systemic fibrosis: a new histopathologic finding.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Severe adverse drug reaction to gadobenate dimeglumine.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: Prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Skin thickening in a hemodialysis patient: a case of nephrogenic fibrosing dermopathy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis in a patient on long-term hemodialysis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis--new clinical entity

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Progressive arm and leg stiffness in a patient with chronic renal impairment.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Spontaneous eruptive keloid-like cutaneous lesions in a renal transplant patient: a form of nephrogenic systemic fibrosis?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?".

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy in children.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088939

Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors

3 December 2018

1 reference

12 December 2020

Safety of gadolinium contrast agent in hemodialysis patients

1 reference

12 December 2020

Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy with systemic involvement

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: two pediatric cases

1 reference

12 December 2020

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin

1 reference

12 December 2020

Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy)

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in two patients with systemic lupus erythematosus

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: a series in a non-Western population

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis

1 reference

12 December 2020

Scleroderma-like syndrome triggered by gadolinium

1 reference

12 December 2020

Nephrogenic systemic fibrosis mimicking inflammatory breast carcinoma

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: a new clinical entity mimicking scleroderma

1 reference

12 December 2020

Case-control study of gadodiamide-related nephrogenic systemic fibrosis

1 reference

12 December 2020

[Nephrogenic systemic fibrosis: more hard times for renal failure patients]

1 reference

12 December 2020

Nephrogenic Systemic Fibrosis: A Mysterious Disease in Patients with Renal Failure--Role of Gadolinium-Based Contrast Media in Causation and the Beneficial Effect of Intravenous Sodium Thiosulfate

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure

1 reference

12 December 2020

Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure

1 reference

12 December 2020

[Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?]

1 reference

12 December 2020

Nephrogenic systemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing's sarcoma, end-stage renal disease, and hemodialysis

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a clinicopathologic study of 6 cases

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in a peritoneal dialysis patient

1 reference

12 December 2020

Neuromuscular involvement in nephrogenic systemic fibrosis

1 reference

12 December 2020

Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient

1 reference

12 December 2020

High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent

1 reference

12 December 2020

Quiz page February 2008: A hemodialysis patient with thickened skin. Nephrogenic fibrosing dermopathy

1 reference

12 December 2020

Localized nephrogenic fibrosing dermopathy: Aberrant dermal repairing?

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a report of 29 cases

1 reference

12 December 2020

Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor

1 reference

12 December 2020

Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation

1 reference

12 December 2020

Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia

1 reference

12 December 2020

Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause

1 reference

12 December 2020

Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case

1 reference

12 December 2020

Nephrogenic systemic fibrosis in a Chinese renal-transplant recipient

1 reference

12 December 2020

Case report. Appearance of nephrogenic fibrosing dermopathy on a bone scan

1 reference

12 December 2020

Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases

1 reference

12 December 2020

Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 tesla

1 reference

12 December 2020

Gadolinium-induced systemic fibrosis in advanced kidney failure

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a pathologic study of autopsy cases

1 reference

12 December 2020

Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation

1 reference

12 December 2020

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol

1 reference

12 December 2020

Outpatient liver biopsy: how safe is it?

1 reference

12 December 2020

Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Identifiers

DOI

10.4103/0019-5154.77556

1 reference

24 August 2017

1 reference

24 August 2017

PubMed publication ID

21572796

1 reference